Role of substance P in viral myocarditis in mice

Yong Wang1, Miho Shimada, Yawei Xu

  • 1Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Kawaracho Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.

Heart and Vessels
|August 3, 2010
PubMed

Insights

Substance P (SP) levels in the heart and blood decrease during viral myocarditis in mice. This suggests SP

Area of Science:

  • Neuroimmunology
  • Cardiovascular Research
  • Virology

Background:

  • Substance P (SP) is a neuropeptide found in the central and peripheral nervous systems, including myocardial nerves.
  • Viral myocarditis is an inflammatory condition of the heart muscle often caused by viral infections.

Purpose of the Study:

  • To investigate the role and levels of Substance P in viral myocarditis induced by encephalomyocarditis virus (EMCV) in a mouse model.
  • To explore the relationship between SP levels and cardiac pathology during viral myocarditis.

Main Methods:

  • Immunohistochemistry was used to examine SP localization in heart tissue.
  • Enzyme immunoassay was employed to quantify SP concentrations in heart and serum samples.
  • Viral myocarditis was induced in mice using EMCV.

Main Results:

  • SP levels and the density of SP-containing cells in the heart were significantly decreased in EMCV-infected mice compared to controls at day 6 post-infection.
  • A negative correlation was observed between cardiac SP levels and the heart weight-to-body weight ratio in infected mice.
  • Circulating SP levels were reduced in infected mice at both day 6 and day 14 post-infection.

Conclusions:

  • Substance P levels are diminished in both the heart and circulation during viral myocarditis in mice.
  • These findings suggest a potential role for SP in the pathogenesis of viral myocarditis.
  • The study highlights the importance of the interplay between the neuropeptide nervous system and the mast-cell immune system in viral myocarditis.